Faculty

Institution

Unit

Venue

Shivi Jain

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneShivi Jain is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shivi Jain

Rush University

You can click a keyword to filter the displayed items

medicine hematology covid-19 infectious diseases (medical specialty) pharmacology thrombosis covid-19 pandemic medical virology hospital infections venous thrombosis immunology pharmacotherapy blood purification communicable diseases applied pharmacology immune thrombocytopenia covid-19 patients dermatology veterinary medicine nephrology chronic kidney disease anatomical pathology hepatitis redox biology leukemia experimental medicine obstetrics and gynaecology respiratory medicine heme homeostasis blood cells disease physiology hematological malignancies kidney failure anticoagulants viral hepatitis aplastic anemia blood platelet lymphoid neoplasia lymphatic disease pharmacokinetics treatment development high-risk pregnancies drug safety therapeutic drug monitoring clinical therapeutics antiviral therapy cancer treatment coagulopathy blood donation clinical infectious disease acute care additional efficacy analysis sickle cell disease multi-organ failure uncommon presentation case report elderly male pernicious anaemia ebv-associated hepatitis autoimmune thyroiditis clinical study newly-diagnosed hiv otherwise specified challenging diagnosis disease severity

Notable Scholarly Works

Notable Federal Grants

Collaborators

Aplastic Anaemia, Pernicious Anaemia and Autoimmune Thyroiditis Following an Episode of Ebv-Associated Hepatitis. BMJ Case Reports (2025)

viral hepatitisautoimmune thyroiditisinfectious diseasesebv-associated hepatitisaplastic anemiainfectious diseases (medical specialty)hepatitispernicious anaemia

Navigating Hyperhemolysis in Sickle Cell Disease: Insights From Literature. Diagnostics (2025)

hematologyblood cellscell biologyredox biologyheme homeostasisblood purificationdisease physiologysickle cell disease

A Challenging Diagnosis of Hhv-8-Associated Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, in a Young Man With Newly-Diagnosed Hiv. American Journal of Case Reports (2024)

hivlymphatic diseasenewly-diagnosed hivlymphoid neoplasiaotherwise specifiedchallenging diagnosispathology

Uncommon Presentation of Post-Transfusion Purpura in an Elderly Male: A Case Report and Unique Alloantibody Identification. American Journal of Case Reports (2024)

anatomical pathologycase reportuncommon presentationelderly male

Additional Efficacy Analysis of Avatrombopag Phase III Data for the Treatment of Adults With Immune Thrombocytopenia. Platelets (2023)

Shivi JainTerry GernsheimerScott KolodnyChelsea BernheiselMichael VredenburgSandhya R. Panch

hematologyadditional efficacy analysisveterinary medicinedermatologyimmunologypharmacologyimmune thrombocytopenia

Cryocrystalglobulinemia Leading to Multi-Organ Failure in Chronic Lymphocytic Leukemia Achieving Complete Renal Recovery. Journal of Hematology (2023)

urologyhematologychronic kidney diseasemedicinehematological malignancieskidney failureleukemiablood purificationnephrologymulti-organ failurepathology

Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia. Blood (2022)

hematologymedicineoncologychemotherapy dose reductionscancer treatmentpharmacotherapy

249: Precision Dosing and Safety of Enoxaparin in High-Risk Patients With Covid-19. Critical Care Medicine (2021)

covid-19medicineclinical epidemiologyhospital infectionsclinical therapeuticssars-cov-2therapeutic drug monitoringpharmacologyapplied pharmacologyantiviral therapyindividualized medicineclinical researchpharmacotherapydrug safety

Heparin Induced Thrombocytopenia in Patients With Covid-19. Research Square (2021)

hepatologyhematologycovid-19infectious diseasesmedical virologysars-cov-2coagulopathyheparin induced thrombocytopeniathrombosis

Impact of Blood Type on Thrombosis and Disease Severity in Adult Covid-19 Patients. Thrombosis Research (2021)

covid-19medicinecovid-19 pandemicinfectious diseasesadult covid-19 patientsmedical virologyblood typeinfectious diseases (medical specialty)venous thrombosisdisease severitythrombosisepidemiology

1
2
10 / page

Shivi Jain

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneShivi Jain is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shivi Jain

Rush University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Aplastic Anaemia, Pernicious Anaemia and Autoimmune Thyroiditis Following an Episode of Ebv-Associated Hepatitis. BMJ Case Reports (2025)

viral hepatitisautoimmune thyroiditisinfectious diseasesebv-associated hepatitisaplastic anemiainfectious diseases (medical specialty)hepatitispernicious anaemia

Navigating Hyperhemolysis in Sickle Cell Disease: Insights From Literature. Diagnostics (2025)

hematologyblood cellscell biologyredox biologyheme homeostasisblood purificationdisease physiologysickle cell disease

A Challenging Diagnosis of Hhv-8-Associated Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, in a Young Man With Newly-Diagnosed Hiv. American Journal of Case Reports (2024)

hivlymphatic diseasenewly-diagnosed hivlymphoid neoplasiaotherwise specifiedchallenging diagnosispathology

Uncommon Presentation of Post-Transfusion Purpura in an Elderly Male: A Case Report and Unique Alloantibody Identification. American Journal of Case Reports (2024)

anatomical pathologycase reportuncommon presentationelderly male

Additional Efficacy Analysis of Avatrombopag Phase III Data for the Treatment of Adults With Immune Thrombocytopenia. Platelets (2023)

Shivi JainTerry GernsheimerScott KolodnyChelsea BernheiselMichael VredenburgSandhya R. Panch

hematologyadditional efficacy analysisveterinary medicinedermatologyimmunologypharmacologyimmune thrombocytopenia

Cryocrystalglobulinemia Leading to Multi-Organ Failure in Chronic Lymphocytic Leukemia Achieving Complete Renal Recovery. Journal of Hematology (2023)

urologyhematologychronic kidney diseasemedicinehematological malignancieskidney failureleukemiablood purificationnephrologymulti-organ failurepathology

Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia. Blood (2022)

hematologymedicineoncologychemotherapy dose reductionscancer treatmentpharmacotherapy

249: Precision Dosing and Safety of Enoxaparin in High-Risk Patients With Covid-19. Critical Care Medicine (2021)

Heparin Induced Thrombocytopenia in Patients With Covid-19. Research Square (2021)

hepatologyhematologycovid-19infectious diseasesmedical virologysars-cov-2coagulopathyheparin induced thrombocytopeniathrombosis

Impact of Blood Type on Thrombosis and Disease Severity in Adult Covid-19 Patients. Thrombosis Research (2021)

covid-19medicinecovid-19 pandemicinfectious diseasesadult covid-19 patientsmedical virologyblood typeinfectious diseases (medical specialty)venous thrombosisdisease severitythrombosisepidemiology

1
2
10 / page